MA
Modus Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.6M | Buy |
24,758
+107
| +0.4% | +$19.9K | 1.37% | 27 |
|
|
2025
Q1 | $5.16M | Buy |
24,651
+115
| +0.5% | +$24.1K | 1.69% | 22 |
|
|
2024
Q4 | $4.36M | Buy |
24,536
+428
| +2% | +$76.1K | 1.37% | 28 |
|
|
2024
Q3 | $4.76M | Buy |
24,108
+289
| +1% | +$57.1K | 1.56% | 24 |
|
|
2024
Q2 | $4.09M | Buy |
23,819
+660
| +3% | +$113K | 1.45% | 24 |
|
|
2024
Q1 | $4.22M | Buy |
23,159
+450
| +2% | +$81.9K | 1.56% | 23 |
|
|
2023
Q4 | $3.52M | Buy |
22,709
+494
| +2% | +$76.6K | 1.43% | 25 |
|
|
2023
Q3 | $3.31M | Buy |
22,215
+341
| +2% | +$50.8K | 1.44% | 25 |
|
|
2023
Q2 | $2.95M | Buy |
21,874
+1,092
| +5% | +$147K | 1.27% | 28 |
|
|
2023
Q1 | $3.31M | Buy |
20,782
+82
| +0.4% | +$13.1K | 1.53% | 21 |
|
|
2022
Q4 | $3.35M | Buy |
20,700
+224
| +1% | +$36.2K | 1.62% | 19 |
|
|
2022
Q3 | $2.75M | Buy |
20,476
+30
| +0.1% | +$4.03K | 1.45% | 26 |
|
|
2022
Q2 | $3.13M | Buy |
20,446
+539
| +3% | +$82.6K | 1.59% | 23 |
|
|
2022
Q1 | $3.23M | Buy |
19,907
+69
| +0.3% | +$11.2K | 1.42% | 25 |
|
|
2021
Q4 | $2.69M | Sell |
19,838
-622
| -3% | -$84.2K | 1.14% | 32 |
|
|
2021
Q3 | $2.21M | Buy |
20,460
+799
| +4% | +$86.2K | 0.96% | 33 |
|
|
2021
Q2 | $2.22M | Sell |
19,661
-487
| -2% | -$54.9K | 0.93% | 33 |
|
|
2021
Q1 | $2.18M | Buy |
20,148
+1,825
| +10% | +$197K | 1.01% | 33 |
|
|
2020
Q4 | $1.96M | Buy |
18,323
+1,152
| +7% | +$123K | 1.02% | 32 |
|
|
2020
Q3 | $1.5M | Buy |
17,171
+4,389
| +34% | +$384K | 0.86% | 37 |
|
|
2020
Q2 | $1.26M | Buy |
12,782
+4,083
| +47% | +$401K | 0.82% | 35 |
|
|
2020
Q1 | $663K | Buy |
+8,699
| New | +$663K | 0.61% | 28 |
|